Compliance & Validation — Documented
ISO 27001
Clinical trial site marketplace connecting sponsors with community research sites to broaden trial access and enrollment.
Inato, founded in 2016 and headquartered in Paris, France, operates a marketplace that connects trial sponsors with community-based research sites, aiming to widen geographic and demographic reach in site selection and enrollment. The company raised a $20M Series A2 in 2023. Its own security FAQ documents ISO 27001 certification; request the certificate and scope during evaluation.
64% — Partial coverage. Coverage score — how completely Atlas documents Inato across 7 buyer-evaluation areas. Reflects available Atlas data, not solution quality.
ISO 27001
cloud
Ask the vendor: What is your pricing model, and what drives total cost of ownership?
Ask the vendor: What is a realistic implementation timeline, and what onboarding support is included?
Mid-Size Biotech, Large Pharma, Top 20 Pharma, CRO / CDMO, Clinical Operations
Patient Recruitment
Series A, Founded 2016
Not captured in Atlas data — confirm directly. Excluded from the score above.
Who owns model outputs? Is our proprietary data used to train models others can access, and where does our data reside?
Can you share validation studies or benchmarks, explain how the model reaches its conclusions, and describe how bias and drift are monitored?